Abstract
Monascus, fermented rice (red mold rice), has been found to reduce the serum total cholesterol and triglyceride due to presence of lovastatin. Lovastatin acts as an inhibitor of 3-hydroxy-3-methyl glutaryl coenzyme A reductase. Coculture of Monascus purpureus MTCC 369 and Monascus ruber MTCC 1880 was used to produce red mold rice by solid-state fermentation. Optimization of different fermentation process parameters such as temperature, fermentation time, inoculum volume, and pH of the solid medium was carried out by Box–Behnken’s factorial design of response surface methodology to maximize lovastatin concentration in red mold rice. Maximum lovastatin production of 2.83 mg/g was predicted at 14th day in solid medium under optimized process condition.
Similar content being viewed by others
References
Alberts, A. W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., et al. (1980). Mevinolin: A highly potent competitive inhibitor of hydroxymethyl glutaryl coenzyme A reductase and cholesterol lowering agent. Proceedings of the National Academy of Sciences of the United States of America, 77(7), 3957–3961.
Banerjee, R., Mukherjee, G., & Patra, K. C. (2005). Microbial transformation of tannin-rich substrate to gallic acid through co culture method. Bioresource Technology, 96(8), 949–953.
Chang, Y. N., Huang, J. C., Lee, C. C., Shih, I. L., & Tzeng, Y. M. (2002). Use of response surface methodology to optimize production of lovastatin by Monascus ruber. Enzyme and Microbial Technology, 30(7), 889–894.
Chen, F., & Hu, X. (2005). Study on red fermented rice with high concentration of monacolin K and low concentration of citrinin. International Journal of Food Microbiology, 103(3), 331–337.
Chiu, C. H., Ni, K. H., Guu, Y. K., & Pan, T. M. (2006). production of red mold rice using a modified Nagata type Koji marker. Applied Microbiology and Biotechnology, 73(2), 297–304.
Demain, A. L. (1999). Pharmaceutically active secondary metabolites of microorganisms. Applied Microbiology and Biotechnology, 52(4), 455–463.
Hajjaj, H., Niedberger, P., & Duboc, P. (2001). Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Applied and Environmental Microbiology, 67(6), 2596–2604.
Kohama, Y., Matsumoto, S., Mimura, T., Tanabe, N., Inada, A., & Nakanishi, T. (1987). Isolation and identification of hypotensive principles in red-mold rice. Chemical and Pharmaceutical Bulletin, 35(6), 2484–2489.
Lee, C. L., Tsai, T. Y., Wang, J. J., & Pan, T. M. (2006a). In vivo hypolipidemic effects and safety of low dosage Monascus powder in hamster model of hyperlipidemia. Applied Microbiology and Biotechnology, 70(5), 533–540.
Lee, C. L., Wang, J. J., Kuo, S. L., & Pan, T. M. (2006b). Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agents—monacolin K and antiinflammation agent—monascin. Applied Microbiology and Biotechnology, 72(6), 1254–1262.
Manzoni, M., & Rollini, M. (2002). Biosynthesis and biotechnological production of statins by filamentous fungi and applications of these cholesterol-lowering drugs. Applied Microbiology and Biotechnology, 58(5), 555–564.
Miyake, T., Mori, A., Kii, T., Okuno, T., Usui, Y., Fumihiro, S., et al. (2005). light effects on cell development and secondary metabolism in Monascus. Journal of Industrial Microbiology and Biotechnology, 32(3), 103–108.
Miyake, T., Uchitomo, K., Zhang, M. Y., Kono, I., Nozaki, N., Sammoto, H., et al. (2006). Effects of the principle nutrients on lovastatin production by Monascus pilosus. Bioscience Biotechnology Biochemistry, 70(5), 1154–1159.
Pandey, A., Selvakumar, P., Socool, C. R., & Nigam, P. (1999). Solid-state fermentation for production of industrial enzymes. Current Science, 77(1), 149–162.
Porcel, E. M. R., Lopez, J. L. C., Perez, J. A. S., & Chisti, Y. (2007). Enhanced production of lovastatin in a bubble column by Aspergillus terreus using a two-stage feeding strategy. Journal of Chemical Technology and Biotechnology, 82(1), 58–64.
Samiee, S. M., Moazami, N., Haghighi, S., Mohseni, F. A., Mirdamadi, S., & Bakhtiari, M. R. (2003). Screening of lovastatin production by filamentous fungi. Iranian Biomedical Journal, 7(1), 29–33.
Sayyad, S. A., Panda, B. P., Javed, S., & Ali, M. (2007). Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Applied Microbiology and Biotechnology, 73(5), 1054–1058.
Su, N. W., Lin, Y. L., Lee, M. H., & Ho, C. Y. (2005). Ankaflavin from Monascus-fermented red rice exhibits selective cytotoxic effects and induces cell death on HepG2 cells. Journal of Agriculture and Food Chemistry, 53(6), 1949–1954.
Su, Y. C., Wang, J. J., Lin, T. T., & Pan, T. M. (2003). Production of secondary metabolites, γ-amino butyric acid and monacolin K by Monascus. Journal of Industrial Microbiology and Biotechnology, 30(1), 41–46.
Taira, J., Miyagi, C., & Aniya, Y. (2002). Dimerumic acid as an antioxidant from the mold, Monascus anka: The inhibition mechanisms against lipid peroxidation and hemeprotein-mediated oxidation. Biochemical Pharmacology, 63(5), 1019–1026.
Temudo, M. F., Kleerebezem, R., & Loosdrecht, M. (2007). Influence of the pH on (open) mixed culture fermentation of glucose: A chemostat study. Biotechnology and Bioengineering, 98(1), 69–79.
Tobert, J. A. (2003). Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nature Review Drug Discovery, 2(7), 517–526.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Panda, B.P., Javed, S. & Ali, M. Optimization of Fermentation Parameters for Higher Lovastatin Production in Red Mold Rice through Co-culture of Monascus purpureus and Monascus ruber . Food Bioprocess Technol 3, 373–378 (2010). https://doi.org/10.1007/s11947-008-0072-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11947-008-0072-z